tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GMAB Stock Latest News

Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
Company AnnouncementsGenmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
6d ago
6K
GMAB
Genmab Updates Articles of Association, Expands Capital and Warrant Authorizations
PremiumCompany Announcements
Genmab Updates Articles of Association, Expands Capital and Warrant Authorizations
11d ago
6K
GMAB
Genmab Ends Early‑Stage PRO1160 Cancer Trial: What It Means for GMAB Investors
PremiumCompany Announcements
Genmab Ends Early‑Stage PRO1160 Cancer Trial: What It Means for GMAB Investors
11d ago
GMAB
Genmab Corrects Insider Share Transaction Pricing in March 2 Filings
PremiumCompany Announcements
Genmab Corrects Insider Share Transaction Pricing in March 2 Filings
12d ago
6K
GMAB
Genmab Details February Transactions Under DKK 725 Million Share Buy-back Program
PremiumCompany Announcements
Genmab Details February Transactions Under DKK 725 Million Share Buy-back Program
13d ago
6K
GMAB
Netflix upgraded, Pinterest downgraded: Wall Street’s top analyst calls
PremiumThe FlyNetflix upgraded, Pinterest downgraded: Wall Street’s top analyst calls
13d ago
AZZ
FPS
Genmab initiated with an Overweight at Wells Fargo
Premium
The Fly
Genmab initiated with an Overweight at Wells Fargo
13d ago
GMAB
Genmab Grants New RSUs and Warrants to Staff in February 2026 Incentive Award
Premium
Company Announcements
Genmab Grants New RSUs and Warrants to Staff in February 2026 Incentive Award
16d ago
6K
GMAB
Genmab Updates Articles of Association, Expands Capital and Incentive Authorizations
PremiumCompany Announcements
Genmab Updates Articles of Association, Expands Capital and Incentive Authorizations
18d ago
6K
GMAB
Genmab Announces Capital Increase Following Employee Warrant Exercises
PremiumCompany Announcements
Genmab Announces Capital Increase Following Employee Warrant Exercises
19d ago
6K
GMAB
Genmab Expands Oncology Pipeline With New First-In-Human GEN1106 Trial
PremiumCompany Announcements
Genmab Expands Oncology Pipeline With New First-In-Human GEN1106 Trial
20d ago
GMAB
Genmab Reports Initial Transactions Under February 2026 Share Buy-back Program
PremiumCompany Announcements
Genmab Reports Initial Transactions Under February 2026 Share Buy-back Program
20d ago
6K
GMAB
Genmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
PremiumRatingsGenmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
20d ago
GMAB
Genmab price target lowered to $40 from $45 at Guggenheim
Premium
The Fly
Genmab price target lowered to $40 from $45 at Guggenheim
20d ago
GMAB
Genmab Discloses CFO Insider Share Sale Under EU Market Abuse Rules
Premium
Company Announcements
Genmab Discloses CFO Insider Share Sale Under EU Market Abuse Rules
23d ago
6K
GMAB
Genmab Expands Blood Cancer Pipeline With First-in-Human GEN3018 Trial
PremiumCompany Announcements
Genmab Expands Blood Cancer Pipeline With First-in-Human GEN3018 Trial
24d ago
GMAB
Genmab Expands Oncology Pipeline With New First-in-Human GEN1079 Trial
PremiumCompany Announcements
Genmab Expands Oncology Pipeline With New First-in-Human GEN1079 Trial
24d ago
GMAB
Genmab Calls March 19 AGM to Approve 2025 Results and Capital Reduction
PremiumCompany Announcements
Genmab Calls March 19 AGM to Approve 2025 Results and Capital Reduction
25d ago
6K
GMAB
Genmab: Solid Royalties and Strategic Deals, But 2026 Data Risks Justify Maintaining a Hold at $32 Target
PremiumRatings
Genmab: Solid Royalties and Strategic Deals, But 2026 Data Risks Justify Maintaining a Hold at $32 Target
25d ago
GMAB
Buy Rating Backed by 2026 Oncology Catalysts and Margin Outperformance Driving 40%+ Mid-Term EPS Upside
PremiumRatingsBuy Rating Backed by 2026 Oncology Catalysts and Margin Outperformance Driving 40%+ Mid-Term EPS Upside
25d ago
GMAB
Genmab price target raised to $40 from $39 at H.C. Wainwright
Premium
The Fly
Genmab price target raised to $40 from $39 at H.C. Wainwright
25d ago
GMAB
Genmab Earnings Call Highlights Pipeline-Fueled Growth
Premium
Company Announcements
Genmab Earnings Call Highlights Pipeline-Fueled Growth
26d ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >